Powder: -20°C for 3 years | In solvent: -80°C for 1 year
TGX-221 是一种选择性的、高效的、细胞膜渗透的 PI3K p110β 抑制剂,常用于研究癌症。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 273 | 现货 | ||
2 mg | ¥ 387 | 现货 | ||
5 mg | ¥ 638 | 现货 | ||
10 mg | ¥ 995 | 现货 | ||
25 mg | ¥ 1,970 | 现货 | ||
50 mg | ¥ 3,660 | 现货 | ||
100 mg | ¥ 5,290 | 现货 | ||
500 mg | ¥ 10,900 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 688 | 现货 |
产品描述 | TGX-221, an effective, specific, and cell membrane permeable inhibitor of the PI3K p110β catalytic subunit, is utilized for cancer treatment. |
靶点活性 | p110δ:0.1 μM, p110β:5 nM |
体外活性 | 在小鼠模型中,TGX-221能够改善血流量,增加尾出血和肾出血时间. |
体内活性 | 在J774.2巨噬细胞中,TGX-221能够抑制胰岛素诱导的PKB的Ser473的磷酸化。在体外循环(ECC)模型中, TGX-221抑制血小板-ECC相互作用,血小板聚集和血小板 - 粒细胞结合。在PC3细胞中,TGX-221(0.2-20 μM)能够抑制细胞增殖,降低p110βPI3K亚型的活性。 |
激酶实验 | Lipid kinase activity : IC50 values are measured using a standard lipid kinase activity with PI as a substrate. (i)100 μM cold ATP is used instead of 10 μM, (ii) the DMSO concentration is 1%, and (iii) [γ-33P]ATP is used instead of [γ-32P]ATP. The TLC plates are quantified using a phosphorimager screen. The reported IC50 values are determined by non-linear regression analysis on the basis of at least three independent experiments repeated across multiple preparations of recombinant protein. |
细胞实验 | For measurement of proliferation, cells are seeded in triplicate in 96-well culture plates and incubated overnight to allow cell attachment. The cells are incubated with TGX-221 for 24, 48, and 72 hours. At designated time intervals, cells are quantified by a crystal violet staining-based colorimetric assay. Briefly, cells are fixed by addition of 100 μl of 2.5% glutaraldehyde solution and incubated at room temperature for 30 minutes. Plates are washed three times by submersion in PBS solution. Plates are air-dried and stained by addition of 100 μL of 0.1% solution of crystal violet dissolved in deionized water and incubated for 20 minutes at room temperature, excess dye is removed by extensive washing with deionized water, and plates are air-dried prior to bound dye solubilization in 100 μL of 10% acetic acid. The optical density of dye extracts is measured directly in plates using a microplate reader at 570 nm.(Only for Reference) |
别名 | TGX221 |
分子量 | 364.44 |
分子式 | C21H24N4O2 |
CAS No. | 663619-89-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 18.2 mg/mL (50 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 2.7439 mL | 13.7197 mL | 27.4394 mL | 68.5984 mL |
5 mM | 0.5488 mL | 2.7439 mL | 5.4879 mL | 13.7197 mL | |
10 mM | 0.2744 mL | 1.372 mL | 2.7439 mL | 6.8598 mL | |
20 mM | 0.1372 mL | 0.686 mL | 1.372 mL | 3.4299 mL | |
50 mM | 0.0549 mL | 0.2744 mL | 0.5488 mL | 1.372 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
TGX-221 663619-89-4 PI3K/Akt/mTOR signaling PI3K TGX221 TGX 221 Phosphoinositide 3-kinase Inhibitor inhibit inhibitor